| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 130, 268-280, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
T Kirchner, S Tzartos, F Hoppe, B Schalke, H Wekerle and HK Muller-Hermelink
Institute of Pathology, University of Wurzburg, West Germany.
The authors describe an immunohistologic study of acetylcholine receptor (AChR)-related antigenic determinants in tumor-free thymuses of myasthenia gravis (MG) patients (13 cases) and nonmyasthenic controls (10 cases) and in thymic epithelial tumors of patients with MG (8 cases) and without MG (6 cases). Monoclonal antibodies (MAbs) to the cytoplasmic part and to the extracellular main immunogenic region (MIR) of the alpha subunit of AChRs were used. Their intrathymic binding sites were defined by double-immunostaining, and compared with alpha- bungarotoxin (alpha-Bgt) labeling demonstrated by fluorescence microscopy. Tumor-free thymuses of MG patients and control patients contained cytoplasmic AChR epitopes and alpha-Bgt binding sites on myoid cells and some epithelial cells. Only myoid cells also expressed extracellular MIR epitopes, suggesting that they bear complete AChRs, and are important targets for the autoimmune attack in tumor-free MG thymus. Evidence that AChR-related antigenic determinants of epithelial cells are also significant for MG is provided by our findings in thymic epithelial tumors. All eight tumors with MG but only two out of six tumors without MG showed cytoplasmic AChR epitopes and alpha-Bgt binding sites on neoplastic epithelial cells. Myoid cells and MIR epitopes did not occur in the neoplasms, but in some tumor-free thymic remnants beside thymomas. It is assumed that nonneoplastic and neoplastic thymic epithelial cells contain only incomplete AChRs or AChR-like molecules. The different expression of AChR epitopes in thymic epithelial tumors and tumor-free thymuses might explain some of the heterogeneous region specificities of anti-AChR antibodies in sera of MG patients with and without thymoma.
This article has been cited by other articles:
 |
|
 |
|
  P. STROBEL, W.-Y. CHUANG, S. CHUVPILO, A. ZETTL, T. KATZENBERGER, H. KALBACHER, P. RIECKMANN, W. NIX, B. SCHALKE, R. GOLD, et al. Common Cellular and Diverse Genetic Basis of Thymoma-associated Myasthenia Gravis: Role of MHC Class II and AIRE Genes and Genetic Polymorphisms Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 143 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Liston, D. H.D. Gray, S. Lesage, A. L. Fletcher, J. Wilson, K. E. Webster, H. S. Scott, R. L. Boyd, L. Peltonen, and C. C. Goodnow Gene Dosage-limiting Role of Aire in Thymic Expression, Clonal Deletion, and Organ-specific Autoimmunity J. Exp. Med., October 18, 2004; 200(8): 1015 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. MARX, H. K. MULLER-HERMELINK, and P. STROBEL The Role of Thymomas in the Development of Myasthenia Gravis Ann. N.Y. Acad. Sci., September 1, 2003; 998(1): 223 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Romi, G. O. Skeie, J. A. Aarli, and N. E. Gilhus The Severity of Myasthenia Gravis Correlates With the Serum Concentration of Titin and Ryanodine Receptor Antibodies Arch Neurol, November 1, 2000; 57(11): 1596 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wilisch, S. Gutsche, V. Hoffacker, A. Schultz, S. Tzartos, W. Nix, B. Schalke, C. Schneider, H.-K. Muller-Hermelink, and A. Marx Association of acetylcholine receptor {alpha}-subunit gene expression in mixed thymoma with myasthenia gravis Neurology, April 1, 1999; 52(7): 1460 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Geng, M. Solimena, R. A. Flavell, R. S. Sherwin, and A. C. Hayday Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease PNAS, August 18, 1998; 95(17): 10055 - 10060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Klein, T. Klein, U. Ruther, and B. Kyewski CD4 T Cell Tolerance to Human C-reactive Protein, an Inducible Serum Protein, Is Mediated by Medullary Thymic Epithelium J. Exp. Med., July 1, 1998; 188(1): 5 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. BEESON, A. P. BOND, L. CORLETT, S. J. CURNOW, M. E. HILL, L. W. JACOBSON, C. MACLENNAN, A. MEAGER, A-M. MOODY, P. MOSS, et al. Thymus, Thymoma, and Specific T Cells in Myasthenia Gravis Ann. N.Y. Acad. Sci., May 13, 1998; 841(1): 371 - 387. [Full Text]
|
|
|
|
|
|
J. A. AARLI, G. O. SKEIE, A. MYGLAND, and N. E. GILHUS Muscle Striation Antibodies in Myasthenia Gravis: Diagnostic and Functional Significance Ann. N.Y. Acad. Sci., May 13, 1998; 841(1): 505 - 515. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
